Skip to content

Assessment of Pulmonary Involvement inUlcerative Colitis by Induced Sputum

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00490048
Enrollment
20
Registered
2007-06-22
Start date
2007-06-30
Completion date
2007-06-30
Last updated
2007-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Keywords

Ulcerative colits, lung, Induced sputum, Our aim to evaluate lung involvement in Ulcerative colitis patients by induced sputum

Brief summary

Ulcerative colitis is a systemic disease we assume that extra intestinal involvement as we describein our study( Fireman Z, Osipov A, Kivity S, Kopelman Y, Sternberg A Fireman E: Assessment of pulmonary involvement in Crohn's disease by induced sputum. Am J Gastroenterol 2000;95(30):730-734. )

Detailed description

Twenty Ulcerative colitis patients and 20 control subjects (all nonsmokers) without respiratory symptoms will be tested. The induce sputum by 20' inhalation of 3.5% saline using ultrasonic nebulizer. Samples will studied by differential counts of 200 cells on cytopreps stained by Giemsa. T-lymphocyte subset analyses were done by FACS using three monoclonal antibodies: CD3 = total T cells, CD4 = T helper cells, and CD8 = T suppressor-cytotoxic cells. CD4/CD8 \>2.5 was considered abnormal.

Interventions

PROCEDUREInduced sputum (inhalation of 3.5% saline)

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* All the ulceratvive colitis patients without lung involvmentage 18-75 years of age

Exclusion criteria

* Pregnant women * Non cooperative patients * Smoker * Lung disease

Design outcomes

Primary

MeasureTime frame
lung involvment in Ulcerative colitis patients

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026